Download PDF
Thromb Haemost 1997; 78(02): 969-970
DOI: 10.1055/s-0038-1657668
Letter to the Editor
Schattauer GmbH Stuttgart

Successful Treatment of Lupus Anticoagulant-Hypoprothrombinemia Syndrome Using Intravenous Immunoglobulins

Gilles Pernod
1   The Laboratoire d’Hématologie, Centre de Transfusion Sanguine, Grenoble, France
,
Josiane Arvieux
2   Laboratoire d’Immunologie, Centre de Transfusion Sanguine, Grenoble, France
,
Patrick H Carpentier
3   Service de Médecine Interne- Angiologie, CHU de Grenoble, Centre de Transfusion Sanguine, Grenoble, France
,
Pascal Mossuz
1   The Laboratoire d’Hématologie, Centre de Transfusion Sanguine, Grenoble, France
,
Jean Luc Bosson
3   Service de Médecine Interne- Angiologie, CHU de Grenoble, Centre de Transfusion Sanguine, Grenoble, France
,
Benoît Polack
1   The Laboratoire d’Hématologie, Centre de Transfusion Sanguine, Grenoble, France
› Author Affiliations
Further Information

Publication History

Received 22 1996

Accepted after revision 26 March 1997

Publication Date:
30 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Arvieux J, Damige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-1125
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Fleck RA, Rapaport SI, Rao VM. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519
    CrossrefPubMedGoogle Scholar
  • 3 Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed-immu- noelectrophoresis in patients with lupus inhibitors. Blood 1984; 64: 807-816
    PubMedGoogle Scholar
  • 4 Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-692
    CrossrefPubMedGoogle Scholar
  • 5 Peacock NW, Levine SP. The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sciences 1994; 307: 346-349
    CrossrefPubMedGoogle Scholar
  • 6 Bernini JC, Bushanan GR, Ashcraft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr 1993; 123: 937-939
    CrossrefPubMedGoogle Scholar
  • 7 Lee MT, Nardi MA, Hu G, Hadzi-Nesic J, Karpatkin M. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Am J Hematol 1996; 51: 307-314
    CrossrefPubMedGoogle Scholar
  • 8 Simel DL, St ClairEW, Adams J, Greenberg CS. Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus antico- agulant-hypoprothrombinemia syndrome. Am J Med 1987; 83: 563-566
    CrossrefPubMedGoogle Scholar
  • 9 Mouthon L, Hurez V, Kazatchkine M. Mechanisms of action of intravenous immunoglobulins (IglV) in the treatment of autoimmune diseases. An Med Interne 1993; 144: 506-513
    PubMedGoogle Scholar
  • 10 Carreras LO, Perez GN, Martinuzzo ME, Malan-Borel I, Malbran A, Said PB. Partial neutralization of a lupus anticoagulant by human immunoglobulin. Thromb Haemost 1990; 64: 32-37
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Galli M, Cortelazzo S, Barbui T. In vivo efficacy of intravenous immunoglobulins in patients with lupus anticoagulant is not mediated by an anti- idiotypic mechanism. Am J Hematol 1991; 38: 184-188
    CrossrefPubMedGoogle Scholar
  • 12 Hanley D, Arkel YS, Lynch J, Kamiyama M. Acquired von Willebrand’s syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol 1994; 46: 141-146
    CrossrefPubMedGoogle Scholar
  • 13 Reznikoff-Etievant M, De LachauxY, Marpeau L, Courouce AM. Intravenous immunoglobulin and hepatitis C transmission in healthy pregnant women. Lancet 1992; 340: 986
    PubMedGoogle Scholar